Gut & Microbiome
Ruminococcus bromii enables resistant starch fermentation
In plain terms: Is the gut microbe Ruminococcus bromii key to digesting resistant starch?
Yes, it's the essential first responder, though shown mainly in lab work rather than whole-person trials.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Population patterns (Observational)
How the studies fall
What the evidence shows
R. bromii is the keystone primary degrader of resistant starch; absent it, RS is poorly fermented. Spiking it into low-R.bromii communities restores RS3 fermentation — the molecular basis of RS responder/non-responder status.
The evidence (15)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Mukhopadhya I, Moraïs S, Laverde-Gomez J, Sheridan PO, Walker AW, Kelly W, Klieve AV, Ouwerkerk D, Duncan SH, Louis P, Koropatkin N, Cockburn D, Kibler R, Cooper PJ, Sandoval C, Crost E, Juge N, Bayer EA, Flint HJ 2018 · Environ Microbiol | in-vitro | supports | moderate | Amylosome components and sporulation conserved across colonic/rumen R. bromii strains - shared RS-degradation machinery. |
| Ze X, Duncan SH, Louis P, Flint HJ 2012 · ISME J | in-vitro | supports | high | Ze/Flint 2012 ISME-J founding R.bromii keystone RS degrader. IN-VITRO/ex-vivo |
| Laverde Gomez JA, Mukhopadhya I, Duncan SH, Louis P, Shaw S, Collie-Duguid E, Crost E, Juge N, Flint HJ 2019 · Environ Microbiol | in-vitro | supports | moderate | R. bromii ferments RS3 producing formate/acetate; cross-feeds acetogens - cooperative basis of keystone fermentation. |
| Baxter NT, Schmidt AW, Venkataraman A, Kim KS, Waldron C, Schmidt TM 2019 · mBio | observational | mixed | moderate | RS-driven SCFA shifts depended on baseline community; butyrate response tied to R. bromii/relevant degraders - context-dependent keystone effect. |
| Walker AW, Ince J, Duncan SH, Webster LM, Holtrop G, Ze X, Brown D, Stares MD, Scott P, Bergerat A, Louis P, McIntosh F, Johnstone AM, Lobley GE, Parkhill J, Flint HJ 2011 · ISME J | observational | supports | moderate | Controlled-diet human study: R. bromii among bacteria most strongly increased by dietary resistant starch. |
| Kim YJ, Jung DH, Park CS 2024 · Food Sci Biotechnol | mechanism | supports | moderate | Narrative review: 'This review discusses the effects of RS on gut and highlights its complex interactions with gut flora, especially the Ruminococcaceae family.' States 'Degradation of RS in the gut begins with primary degraders, such as Bifidobacterium adolescentis and Ruminococcus bromii.' No own data. Review — zero weight. |
| Ze X, Le Mougen F, Duncan SH, Louis P, Flint HJ 2013 · Gut Microbes | in-vitro | supports | moderate | Review establishing R. bromii as keystone RS degrader; other species rely on its primary breakdown of resistant starch. |
| Klostermann CE, Fassarella M, Zoetendal EG, Schols HA 2025 · Beneficial microbes | in-vitro | supports | moderate | R. bromii degraded intrinsic RS-3 (all crystal types/chain lengths) gradually to maltose/glucose; B. adolescentis failed on B-type RS-3. Concluded efficient RS-3 degradation requires R. bromii's specific enzyme machinery. |
| Pickens JT, Cockburn DW 2024 · mSphere | observational | supports | low | MSphere 2023 RS-degradation rare trait (R.bromii/B.adolescentis). IN-VITRO |
| Wimmer BH et al 2025 · bioRxiv | in-vitro | supports | moderate | States R. bromii is 'the primary resistant starch (RS) degrader in humans,' relying on the amylosome, a specialized cell-bound enzyme complex; cryo-ET + proteomics show structural/expression-level regulation enabling RS degradation and enzy |
| Cerqueira FM, Photenhauer AL, Doden HL, Brown AN, Abdel-Hamid AM, Moraïs S, Bayer EA, Wawrzak Z, Cann I, Ridlon JM, Hopkins JB, Koropatkin NM 2022 · J Biol Chem | in-vitro | supports | moderate | JBC 2022 Sas20 starch-binding in amylosome. IN-VITRO/mechanism |
| Siziya IN, Park CS, Jung DH 2026 · J Microbiol Biotechnol | observational | supports | low | Narrative review (review-article, no methods section): 'Metagenomic and fermentation studies consistently identify R. bromii as a keystone RS degrader in the human colon' — cited to refs 8, 11-13, not its own data. Review — zero weight. |
| Ze X, Ben David Y, Laverde-Gomez JA, Dassa B, Sheridan PO, Duncan SH, Louis P, Henrissat B, Juge N, Koropatkin NM, Bayer EA, Flint HJ 2015 · mBio | in-vitro | supports | high | MBio 2015 R.bromii amylosome/GH13 for particulate RS. IN-VITRO/mechanism |
| Wimmer BH, Moraïs S, Amit I, Tovar-Herrera O, Tatli M, Trautwein-Schult A, Pfister B, Zalk R, Tödtli P, Simoni S, Lisibach M, Levin L, Becher D, Bayer EA, Medalia O, Mizrahi I 2025 · Nat Commun | mechanism | supports | high | Cryo-ET/proteomics: R. bromii amylosome architecture drives spatially-constrained RS degradation; affirms primary-degrader role. |
| Venkataraman A, Sieber JR, Schmidt AW, Waldron C, Theis KR, Schmidt TM 2016 · Microbiome | observational | supports | moderate | RS supplementation gave variable SCFA/microbiome responses; R. bromii (and others) abundance predicted responder status - keystone but individual-dependent. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.